本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mereo Biopharma Group Plc

2.56
+0.06002.40%
盤後2.640.0800+3.13%17:20 EDT
成交量:261.15萬
成交額:665.49萬
市值:4.07億
市盈率:-8.76
高:2.59
開:2.57
低:2.49
收:2.50
資料載入中...
2021/12/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/29

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/09

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]